These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36780383)

  • 1. Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort.
    Luu JM; Malhotra P; Cook-Wiens G; Pepine CJ; Handberg EM; Reis SE; Reichek N; Bittner V; Wei J; Kelsey SF; Sailaja Marpuri R; Sopko G; Bairey Merz CN
    Circulation; 2023 Feb; 147(7):617-619. PubMed ID: 36780383
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
    Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
    Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
    Eastwood JA; Johnson BD; Rutledge T; Bittner V; Whittaker KS; Krantz DS; Cornell CE; Eteiba W; Handberg E; Vido D; Bairey Merz CN
    J Womens Health (Larchmt); 2013 Sep; 22(9):724-32. PubMed ID: 23992103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.
    Gulati M; Cooper-DeHoff RM; McClure C; Johnson BD; Shaw LJ; Handberg EM; Zineh I; Kelsey SF; Arnsdorf MF; Black HR; Pepine CJ; Merz CN
    Arch Intern Med; 2009 May; 169(9):843-50. PubMed ID: 19433695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.
    Bakir M; Nelson MD; Jones E; Li Q; Wei J; Sharif B; Minissian M; Shufelt C; Sopko G; Pepine CJ; Merz CNB
    Int J Cardiol; 2016 Nov; 223():936-939. PubMed ID: 27589041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
    Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
    J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
    Park K; Quesada O; Cook-Wiens G; Wei J; Minissian M; Handberg EM; Merz NB; Pepine CJ
    J Womens Health (Larchmt); 2020 Apr; 29(4):487-492. PubMed ID: 31859580
    [No Abstract]   [Full Text] [Related]  

  • 8. Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation).
    Sedlak T; Herscovici R; Cook-Wiens G; Handberg E; Wei J; Shufelt C; Bittner V; Reis SE; Reichek N; Pepine C; Bairey Merz CN
    J Am Heart Assoc; 2020 Apr; 9(7):e013234. PubMed ID: 32268814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
    Anderson RD; Petersen JW; Mehta PK; Wei J; Johnson BD; Handberg EM; Kar S; Samuels B; Azarbal B; Kothawade K; Kelsey SF; Sharaf B; Shaw LJ; Sopko G; Bairey Merz CN; Pepine CJ
    J Interv Cardiol; 2019; 2019():7169275. PubMed ID: 31772544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
    Aldiwani H; Zaya M; Suppogu N; Quesada O; Johnson BD; Mehta PK; Shufelt C; Petersen J; Azarbal B; Samuels B; Anderson RD; Shaw LJ; Kar S; Handberg E; Kelsey SF; Pepine CJ; Bairey Merz CN
    J Am Heart Assoc; 2020 Feb; 9(4):e013168. PubMed ID: 32063125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.
    Barsky L; Merz CNB; Wei J; Shufelt C; Handberg E; Pepine C; Rutledge T; Reis S; Doyle M; Rogers W; Shaw L; Sopko G
    Curr Atheroscler Rep; 2020 Jun; 22(8):35. PubMed ID: 32556630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
    Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
    JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender controversies in ischemic heart disease.
    Jameson MG
    Md Med; 2011; 12(1):15-6, 22. PubMed ID: 21657172
    [No Abstract]   [Full Text] [Related]  

  • 14. Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).
    Kenkre TS; Malhotra P; Johnson BD; Handberg EM; Thompson DV; Marroquin OC; Rogers WJ; Pepine CJ; Bairey Merz CN; Kelsey SF
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29217675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
    AlBadri A; Bairey Merz CN; Johnson BD; Wei J; Mehta PK; Cook-Wiens G; Reis SE; Kelsey SF; Bittner V; Sopko G; Shaw LJ; Pepine CJ; Ahmed B
    J Am Coll Cardiol; 2019 Feb; 73(6):684-693. PubMed ID: 30765035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chinese expert consensus on diagnosis and management on patients with ischemia and non-obstructive coronary artery disease].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Dec; 50(12):1148-1160. PubMed ID: 36517435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndrome of Nonobstructive Coronary Artery Diseases: A Comprehensive Overview of Open Artery Ischemia.
    Ya'qoub L; Elgendy IY; Pepine CJ
    Am J Med; 2021 Nov; 134(11):1321-1329. PubMed ID: 34343507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to Pendyal-Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women's Ischemia Syndrome Evaluation (WISE) Cohort.
    Luu JM; Bairey Merz CN; Wei J
    Can J Cardiol; 2024 Jun; 40(6):1177. PubMed ID: 38244985
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
    Doyle M; Weinberg N; Pohost GM; Bairey Merz CN; Shaw LJ; Sopko G; Fuisz A; Rogers WJ; Walsh EG; Johnson BD; Sharaf BL; Pepine CJ; Mankad S; Reis SE; Vido DA; Rayarao G; Bittner V; Tauxe L; Olson MB; Kelsey SF; Biederman RW
    JACC Cardiovasc Imaging; 2010 Oct; 3(10):1030-6. PubMed ID: 20947048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE).
    Wessel TR; Arant CB; McGorray SP; Sharaf BL; Reis SE; Kerensky RA; von Mering GO; Smith KM; Pauly DF; Handberg EM; Mankad S; Olson MB; Johnson BD; Merz CN; Sopko G; Pepine CJ;
    Clin Cardiol; 2007 Feb; 30(2):69-74. PubMed ID: 17326061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.